Comparison · hormone optimization

TRT vs Enclomiphene

TRT introduces exogenous testosterone. Enclomiphene stimulates the body's own production by selectively blocking estrogen receptors at the hypothalamus, which prompts LH and FSH release. Both are provider-reviewed pathways; candidacy depends on fertility goals, baseline biomarkers, and the dominant clinical vector.

Reviewed by Dr. Laura PurdyMay 29, 2026

Attribute

TRT (Testosterone optimization)

Enclomiphene

Mechanism

Exogenous testosterone added to the system

Selective estrogen receptor modulator — drives endogenous LH/FSH and testicular testosterone production

Fertility impact

Suppresses endogenous LH/FSH and can reduce sperm production

Preserves or supports endogenous production; commonly chosen when fertility is a near-term goal

Typical candidates

Adult men with confirmed low T who are not actively pursuing fertility

Adult men with secondary hypogonadism who want to preserve fertility or trial endogenous restoration first

Delivery modality

Injectable, oral, topical, nasal

Oral

Biomarker monitoring

Hormones, Lipids, CBC (hematocrit), CMP on cadence

Hormones (T, LH, FSH, estradiol), Lipids, CBC, CMP on cadence

Expected onset

Subjective signals within 2–4 weeks

LH/FSH and testosterone response within weeks; subjective signals variable

Choose TRT (Testosterone optimization)

TRT is appropriate when the patient is not pursuing near-term fertility and biomarkers/symptoms confirm candidacy.

Explore pathway

Choose Enclomiphene

Enclomiphene is appropriate when fertility preservation is a goal, when the patient prefers to trial endogenous restoration, or when secondary hypogonadism is the dominant vector and the HPG axis is responsive.

Explore pathway

Educational. Final pathway selection is provider-reviewed via synchronous video consultation against your biomarkers, history, and goals.

Frequently asked

Can a patient move from enclomiphene to TRT later?

Yes — many patients trial enclomiphene first and transition to TRT under provider review if the response is insufficient.

Next step

Take the optimization assessment.

The adaptive assessment maps your symptoms, history, and goals to candidate pathways — and routes you into provider review.

Begin assessment